Participants 62 91 4
metastatic colorectal cancer.
Participants 330 449 7
Of 813 patients with previously untreated metastatic colorectal cancer, we randomly assigned 402 to receive irinotecan,
Participants 1837 1894 4
survival among patients with metastatic colorectal cancer
